Neuromodulation in Epilepsy Market By Therapy Type (Vagus Nerve Stimulation (VNS) and Deep Brain Stimulation (DBS)), By Magnetic Stimulation Technique (Single Pulse and Repeated Pulse ), By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 – 2027
Industry Trends
Global neuromodulation in epilepsy market was valued at US$ 1365.89 million in 2018 and is expected to reach US$ 3410.12 million by 2027, growing at an estimated CAGR of 10.71% over the forecast period. Neuromodulation for epilepsy is considered to be an alternative to traditional epilepsy surgical approaches. The same can be bifurcated into two types which is invasive and non-invasive. The U.S. Food and Drug Administration (FDA) granted approval for the use of Deep Brain Stimulation (DBS) therapy by Medtronic as a treatment option for focal epilepsy. Approximately one million people in the United States suffer from uncontrolled epilepsy. It has been duly reported that the total number of seizures decreased by 40% in people who received DBS treatment compared to 15% for those who did not receive DBS treatment. Research and development activities are being undertaken to incorporate seizure forecasting and responsive stimulation into DBS for epilepsy. A project assisted through the NIH BRAIN Initiative Public-Private Partnership Program is expected to conduct clinical research using industry-supplied cutting-edge devices.
Rising demand for minimally invasive procedures is expected to aid the overall neuromodulation in epilepsy market. Non-invasive vagus nerve stimulation devices which do not require surgical implantation have been approved in the European Union to treat epilepsy. A company named LivaNova, a London-based medical medical device manufacturer received an approval for its responsive epilepsy treatment system. Single-pulse and paired-pulse TMS techniques are commonly used to quantify levels of inhibition and cortical excitability. However, their interside and longitudinal intraindividual variability is lower. The recent technological and methodological advances particularly in this field has aided the patients suffering from epilepsy disorders in the recent past and is expected to continue the same trend over the forecast period. The treatment is primarily offered to people who have not responded properly to drug treatment, thus, improving and restoring their overall quality of life.
North America Neuromodulation in Epilepsy Market Revenue & Forecast, (US$ Million), 2015 – 2027
Competitive Landscape
The report provides both, qualitative and quantitative research of neuromodulation in epilepsy market, as well as provides comprehensive insights and favored development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings, specification, pricing, and gross margin.
Some of the players operating in the neuromodulation in epilepsy market are Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Medtronic, NeuroPace, Inc. amongst others.
Neuromodulation in Epilepsy Market:
By Therapy Type
- Vagus Nerve Stimulation (VNS)
- Deep Brain Stimulation (DBS)
By Magnetic Stimulation Technique
- Single pulse
- Repeated pulse
By Geography
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Norway
- Sweden
- Benelux Union
- Belgium
- The Netherlands
- Luxemburg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base Year:
2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid Databases
3.2.2. Secondary
Sources
3.3. Market Size
Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Neuromodulation in Epilepsy Market
6. Market
Synopsis: Neuromodulation in Epilepsy
Market
7. Neuromodulation
in Epilepsy Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Neuromodulation in Epilepsy Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Neuromodulation in Epilepsy Market
7.6. Porter’s Five
Force Analysis
8. Global
Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global
Neuromodulation in Epilepsy Market Revenue (US$ Mn)
8.2. Global
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Therapy
Type
8.2.1. Vagus Nerve
Stimulation (VNS)
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and Penetration, 2015 – 2018
8.2.1.3.
Market Forecast, 2019 – 2027
8.2.1.4.
Compound Annual Growth Rate (CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
North America
8.2.1.5.1.1.
Market Estimation, 2015 – 2018
8.2.1.5.1.2.
Market Forecast, 2019 – 2027
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market Estimation, 2015 – 2018
8.2.1.5.2.2.
Market Forecast, 2019 – 2027
8.2.1.5.3.
Asia Pacific
8.2.1.5.3.1.
Market Estimation, 2015 – 2018
8.2.1.5.3.2.
Market Forecast, 2019 – 2027
8.2.1.5.4.
Middle East and Africa
8.2.1.5.4.1.
Market Estimation, 2015 – 2018
8.2.1.5.4.2.
Market Forecast, 2019 – 2027
8.2.1.5.5.
Latin America
8.2.1.5.5.1.
Market Estimation, 2015 – 2018
8.2.1.5.5.2.
Market Forecast, 2019 – 2027
8.2.2. Deep Brain
Stimulation (DBS)
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and Penetration, 2015 – 2018
8.2.2.3.
Market Forecast, 2019 – 2027
8.2.2.4.
Compound Annual Growth Rate (CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 – 2018
8.2.2.5.1.2.
Market Forecast, 2019 – 2027
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 – 2018
8.2.2.5.2.2.
Market Forecast, 2019 – 2027
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 – 2018
8.2.2.5.3.2.
Market Forecast, 2019 – 2027
8.2.2.5.4.
Middle East and Africa
8.2.2.5.4.1.
Market Estimation, 2015 – 2018
8.2.2.5.4.2.
Market Forecast, 2019 – 2027
8.2.2.5.5.
Latin America
8.2.2.5.5.1.
Market Estimation, 2015 – 2018
8.2.2.5.5.2.
Market Forecast, 2019 – 2027
8.3. Key Segment
for Channeling Investments
8.3.1. By Therapy
Type
9. Global
Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Neuromodulation
in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Magnetic Stimulation
Technique
9.2.1. Single pulse
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and Penetration, 2015 – 2018
9.2.1.3.
Market Forecast, 2019 – 2027
9.2.1.4.
Compound Annual Growth Rate (CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1.
Market Estimation, 2015 – 2018
9.2.1.5.1.2.
Market Forecast, 2019 – 2027
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market Estimation, 2015 – 2018
9.2.1.5.2.2.
Market Forecast, 2019 – 2027
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1.
Market Estimation, 2015 – 2018
9.2.1.5.3.2.
Market Forecast, 2019 – 2027
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1.
Market Estimation, 2015 – 2018
9.2.1.5.4.2.
Market Forecast, 2019 – 2027
9.2.1.5.5.
Latin America
9.2.1.5.5.1.
Market Estimation, 2015 – 2018
9.2.1.5.5.2.
Market Forecast, 2019 – 2027
9.2.2. Repeated pulse
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and Penetration, 2015 – 2018
9.2.2.3.
Market Forecast, 2019 – 2027
9.2.2.4.
Compound Annual Growth Rate (CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 – 2018
9.2.2.5.1.2.
Market Forecast, 2019 – 2027
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market Estimation, 2015 – 2018
9.2.2.5.2.2.
Market Forecast, 2019 – 2027
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 – 2018
9.2.2.5.3.2.
Market Forecast, 2019 – 2027
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 – 2018
9.2.2.5.4.2.
Market Forecast, 2019 – 2027
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 – 2018
9.2.2.5.5.2.
Market Forecast, 2019 – 2027
9.3. Key Segment
for Channeling Investments
9.3.1. By Magnetic
Stimulation Technique
10. North America
Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1.
North America Neuromodulation in Epilepsy Market Revenue (US$
Mn)
10.2. North America
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Therapy
Type
10.2.1.
Vagus Nerve Stimulation (VNS)
10.2.2.
Deep Brain Stimulation (DBS)
10.3. North America
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Magnetic
Stimulation Technique
10.3.1.
Single pulse
10.3.2.
Repeated pulse
10.4. North America
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Country
10.4.1.
U.S
10.4.1.1.
U.S Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
10.4.1.1.1.
Vagus Nerve Stimulation (VNS)
10.4.1.1.2.
Deep Brain Stimulation (DBS)
10.4.1.2.
U.S Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
10.4.1.2.1.
Single pulse
10.4.1.2.2.
Repeated pulse
10.4.2.
Canada
10.4.2.1.
Canada Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
10.4.2.1.1.
Vagus Nerve Stimulation (VNS)
10.4.2.1.2.
Deep Brain Stimulation (DBS)
10.4.2.2.
Canada Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
10.4.2.2.1.
Single pulse
10.4.2.2.2.
Repeated pulse
10.4.3.
Mexico
10.4.3.1.
Mexico Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
10.4.3.1.1.
Vagus Nerve Stimulation (VNS)
10.4.3.1.2.
Deep Brain Stimulation (DBS)
10.4.3.2.
Mexico Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
10.4.3.2.1.
Single pulse
10.4.3.2.2.
Repeated pulse
10.4.4.
Rest of North America
10.4.4.1.
Rest of North America Neuromodulation in Epilepsy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
10.4.4.1.1.
Vagus Nerve Stimulation (VNS)
10.4.4.1.2.
Deep Brain Stimulation (DBS)
10.4.4.2.
Rest of North America Neuromodulation in Epilepsy Market
Revenue (US$ Mn) and Forecasts, By Magnetic Stimulation Technique
10.4.4.2.1.
Single pulse
10.4.4.2.2.
Repeated pulse
10.5. Key Segment
for Channeling Investments
10.5.1.
By Country
10.5.2.
By Therapy Type
10.5.3.
By Magnetic Stimulation Technique
11. Europe
Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 - 2027
11.1. Overview
11.1.1.
Europe Neuromodulation in Epilepsy Market Revenue (US$ Mn)
11.2. Europe
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Therapy
Type
11.2.1.
Vagus Nerve Stimulation (VNS)
11.2.2.
Deep Brain Stimulation (DBS)
11.3. Europe
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Magnetic
Stimulation Technique
11.3.1.
Single pulse
11.3.2.
Repeated pulse
11.4. Europe
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Country
11.4.1.
France
11.4.1.1.
France Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
11.4.1.1.1.
Vagus Nerve Stimulation (VNS)
11.4.1.1.2.
Deep Brain Stimulation (DBS)
11.4.1.2.
France Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
11.4.1.2.1.
Single pulse
11.4.1.2.2.
Repeated pulse
11.4.2.
The UK
11.4.2.1.
The UK Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
11.4.2.1.1.
Vagus Nerve Stimulation (VNS)
11.4.2.1.2.
Deep Brain Stimulation (DBS)
11.4.2.2.
The UK Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
11.4.2.2.1.
Single pulse
11.4.2.2.2.
Repeated pulse
11.4.3.
Spain
11.4.3.1.
Spain Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
11.4.3.1.1.
Vagus Nerve Stimulation (VNS)
11.4.3.1.2.
Deep Brain Stimulation (DBS)
11.4.3.2.
Spain Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
11.4.3.2.1.
Single pulse
11.4.3.2.2.
Repeated pulse
11.4.4.
Germany
11.4.4.1.
Germany Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
11.4.4.1.1.
Vagus Nerve Stimulation (VNS)
11.4.4.1.2.
Deep Brain Stimulation (DBS)
11.4.4.2.
Germany Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
11.4.4.2.1.
Single pulse
11.4.4.2.2.
Repeated pulse
11.4.5.
Italy
11.4.5.1.
Italy Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
11.4.5.1.1.
Vagus Nerve Stimulation (VNS)
11.4.5.1.2.
Deep Brain Stimulation (DBS)
11.4.5.2.
Italy Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
11.4.5.2.1.
Single pulse
11.4.5.2.2.
Repeated pulse
11.4.6.
Nordic Countries
11.4.6.1.
Nordic Countries Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
11.4.6.1.1.
Vagus Nerve Stimulation (VNS)
11.4.6.1.2.
Deep Brain Stimulation (DBS)
11.4.6.2.
Nordic Countries Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Magnetic Stimulation Technique
11.4.6.2.1.
Single pulse
11.4.6.2.2.
Repeated pulse
11.4.6.3.
Nordic Countries Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Country
11.4.6.3.1.
Denmark
11.4.6.3.2.
Finland
11.4.6.3.3.
Iceland
11.4.6.3.4.
Sweden
11.4.6.3.5.
Norway
11.4.7.
Benelux Union
11.4.7.1.
Benelux Union Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
11.4.7.1.1.
Vagus Nerve Stimulation (VNS)
11.4.7.1.2.
Deep Brain Stimulation (DBS)
11.4.7.2.
Benelux Union Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Magnetic Stimulation Technique
11.4.7.2.1.
Single pulse
11.4.7.2.2.
Repeated pulse
11.4.7.3.
Benelux Union Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Country
11.4.7.3.1.
Belgium
11.4.7.3.2.
The Netherlands
11.4.7.3.3.
Luxembourg
11.4.8.
Rest of Europe
11.4.8.1.
Rest of Europe Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
11.4.8.1.1.
Vagus Nerve Stimulation (VNS)
11.4.8.1.2.
Deep Brain Stimulation (DBS)
11.4.8.2.
Rest of Europe Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Magnetic Stimulation Technique
11.4.8.2.1.
Single pulse
11.4.8.2.2.
Repeated pulse
11.5. Key Segment
for Channeling Investments
11.5.1.
By Country
11.5.2.
By Therapy Type
11.5.3.
By Magnetic Stimulation Technique
12. Asia Pacific
Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1.
Asia Pacific Neuromodulation in Epilepsy Market Revenue (US$
Mn)
12.2. Asia Pacific
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Therapy
Type
12.2.1.
Vagus Nerve Stimulation (VNS)
12.2.2.
Deep Brain Stimulation (DBS)
12.3. Asia Pacific
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Magnetic
Stimulation Technique
12.3.1.
Single pulse
12.3.2.
Repeated pulse
12.4. Asia Pacific
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Country
12.4.1.
China
12.4.1.1.
China Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
12.4.1.1.1.
Vagus Nerve Stimulation (VNS)
12.4.1.1.2.
Deep Brain Stimulation (DBS)
12.4.1.2.
China Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
12.4.1.2.1.
Single pulse
12.4.1.2.2.
Repeated pulse
12.4.2.
Japan
12.4.2.1.
Japan Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
12.4.2.1.1.
Vagus Nerve Stimulation (VNS)
12.4.2.1.2.
Deep Brain Stimulation (DBS)
12.4.2.2.
Japan Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
12.4.2.2.1.
Single pulse
12.4.2.2.2.
Repeated pulse
12.4.3.
India
12.4.3.1.
India Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
12.4.3.1.1.
Vagus Nerve Stimulation (VNS)
12.4.3.1.2.
Deep Brain Stimulation (DBS)
12.4.3.2.
India Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
12.4.3.2.1.
Single pulse
12.4.3.2.2.
Repeated pulse
12.4.4.
New Zealand
12.4.4.1.
New Zealand Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
12.4.4.1.1.
Vagus Nerve Stimulation (VNS)
12.4.4.1.2.
Deep Brain Stimulation (DBS)
12.4.4.2.
New Zealand Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Magnetic Stimulation Technique
12.4.4.2.1.
Single pulse
12.4.4.2.2.
Repeated pulse
12.4.5.
Australia
12.4.5.1.
Australia Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
12.4.5.1.1.
Vagus Nerve Stimulation (VNS)
12.4.5.1.2.
Deep Brain Stimulation (DBS)
12.4.5.2.
Australia Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
12.4.5.2.1.
Single pulse
12.4.5.2.2.
Repeated pulse
12.4.6.
South Korea
12.4.6.1.
South Korea Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
12.4.6.1.1.
Vagus Nerve Stimulation (VNS)
12.4.6.1.2.
Deep Brain Stimulation (DBS)
12.4.6.2.
South Korea Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Magnetic Stimulation Technique
12.4.6.2.1.
Single pulse
12.4.6.2.2.
Repeated pulse
12.4.7.
Southeast Asia
12.4.7.1.
Southeast Asia Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Therapy Type
12.4.7.1.1.
Vagus Nerve Stimulation (VNS)
12.4.7.1.2.
Deep Brain Stimulation (DBS)
12.4.7.2.
Southeast Asia Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Magnetic Stimulation Technique
12.4.7.2.1.
Single pulse
12.4.7.2.2.
Repeated pulse
12.4.7.3.
Southeast Asia Neuromodulation in Epilepsy Market Revenue
(US$ Mn) and Forecasts, By Country
12.4.7.3.1.
Indonesia
12.4.7.3.2.
Thailand
12.4.7.3.3.
Malaysia
12.4.7.3.4.
Singapore
12.4.7.3.5.
Rest of Southeast Asia
12.4.8.
Rest of Asia Pacific
12.4.8.1.
Rest of Asia Pacific Neuromodulation in Epilepsy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
12.4.8.1.1.
Vagus Nerve Stimulation (VNS)
12.4.8.1.2.
Deep Brain Stimulation (DBS)
12.4.8.2.
Rest of Asia Pacific Neuromodulation in Epilepsy Market
Revenue (US$ Mn) and Forecasts, By Magnetic Stimulation Technique
12.4.8.2.1.
Single pulse
12.4.8.2.2.
Repeated pulse
12.5. Key Segment
for Channeling Investments
12.5.1.
By Country
12.5.2.
By Therapy Type
12.5.3.
By Magnetic Stimulation Technique
13. Middle East
and Africa Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 -
2027
13.1. Overview
13.1.1.
Middle East and Africa Neuromodulation in Epilepsy Market
Revenue (US$ Mn)
13.2. Middle East
and Africa Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts,
By Therapy Type
13.2.1.
Vagus Nerve Stimulation (VNS)
13.2.2.
Deep Brain Stimulation (DBS)
13.3. Middle East
and Africa Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts,
By Magnetic Stimulation Technique
13.3.1.
Single pulse
13.3.2.
Repeated pulse
13.4. Middle East
and Africa Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts,
By Country
13.4.1.
Saudi Arabia
13.4.1.1.
Saudi Arabia Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.4.1.1.1.
Vagus Nerve Stimulation (VNS)
13.4.1.1.2.
Deep Brain Stimulation (DBS)
13.4.1.2.
Saudi Arabia Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Magnetic Stimulation Technique
13.4.1.2.1.
Single pulse
13.4.1.2.2.
Repeated pulse
13.4.2.
UAE
13.4.2.1.
UAE Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
13.4.2.1.1.
Vagus Nerve Stimulation (VNS)
13.4.2.1.2.
Deep Brain Stimulation (DBS)
13.4.2.2.
UAE Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
13.4.2.2.1.
Single pulse
13.4.2.2.2.
Repeated pulse
13.4.3.
Egypt
13.4.3.1.
Egypt Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Therapy Type
13.4.3.1.1.
Vagus Nerve Stimulation (VNS)
13.4.3.1.2.
Deep Brain Stimulation (DBS)
13.4.3.2.
Egypt Neuromodulation in Epilepsy Market Revenue (US$ Mn) and
Forecasts, By Magnetic Stimulation Technique
13.4.3.2.1.
Single pulse
13.4.3.2.2.
Repeated pulse
13.4.4.
Kuwait
13.4.4.1.
Kuwait Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
13.4.4.1.1.
Vagus Nerve Stimulation (VNS)
13.4.4.1.2.
Deep Brain Stimulation (DBS)
13.4.4.2.
Kuwait Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
13.4.4.2.1.
Single pulse
13.4.4.2.2.
Repeated pulse
13.4.5.
South Africa
13.4.5.1.
South Africa Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Therapy Type
13.4.5.1.1.
Vagus Nerve Stimulation (VNS)
13.4.5.1.2.
Deep Brain Stimulation (DBS)
13.4.5.2.
South Africa Neuromodulation in Epilepsy Market Revenue (US$
Mn) and Forecasts, By Magnetic Stimulation Technique
13.4.5.2.1.
Single pulse
13.4.5.2.2.
Repeated pulse
13.4.6.
Rest of Middle East & Africa
13.4.6.1.
Rest of Middle East & Africa Neuromodulation in Epilepsy
Market Revenue (US$ Mn) and Forecasts, By Therapy Type
13.4.6.1.1.
Vagus Nerve Stimulation (VNS)
13.4.6.1.2.
Deep Brain Stimulation (DBS)
13.4.6.2.
Rest of Middle East & Africa Neuromodulation in Epilepsy
Market Revenue (US$ Mn) and Forecasts, By Magnetic Stimulation Technique
13.4.6.2.1.
Single pulse
13.4.6.2.2.
Repeated pulse
13.5. Key Segment
for Channeling Investments
13.5.1.
By Country
13.5.2.
By Therapy Type
13.5.3.
By Magnetic Stimulation Technique
14. Latin America
Neuromodulation in Epilepsy Market Analysis and Forecasts, 2019 - 2027
14.1. Overview
14.1.1.
Latin America Neuromodulation in Epilepsy Market Revenue (US$
Mn)
14.2. Latin America
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Therapy
Type
14.2.1.
Vagus Nerve Stimulation (VNS)
14.2.2.
Deep Brain Stimulation (DBS)
14.3. Latin America
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Magnetic
Stimulation Technique
14.3.1.
Single pulse
14.3.2.
Repeated pulse
14.4. Latin America
Neuromodulation in Epilepsy Market Revenue (US$ Mn) and Forecasts, By Country
14.4.1.
Brazil
14.4.1.1.
Brazil Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
14.4.1.1.1.
Vagus Nerve Stimulation (VNS)
14.4.1.1.2.
Deep Brain Stimulation (DBS)
14.4.1.2.
Brazil Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
14.4.1.2.1.
Single pulse
14.4.1.2.2.
Repeated pulse
14.4.2.
Argentina
14.4.2.1.
Argentina Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Therapy Type
14.4.2.1.1.
Vagus Nerve Stimulation (VNS)
14.4.2.1.2.
Deep Brain Stimulation (DBS)
14.4.2.2.
Argentina Neuromodulation in Epilepsy Market Revenue (US$ Mn)
and Forecasts, By Magnetic Stimulation Technique
14.4.2.2.1.
Single pulse
14.4.2.2.2.
Repeated pulse
14.4.3.
Rest of Latin America
14.4.3.1.
Rest of Latin America Neuromodulation in Epilepsy Market
Revenue (US$ Mn) and Forecasts, By Therapy Type
14.4.3.1.1.
Vagus Nerve Stimulation (VNS)
14.4.3.1.2.
Deep Brain Stimulation (DBS)
14.4.3.2.
Rest of Latin America Neuromodulation in Epilepsy Market
Revenue (US$ Mn) and Forecasts, By Magnetic Stimulation Technique
14.4.3.2.1.
Single pulse
14.4.3.2.2.
Repeated pulse
14.5. Key Segment
for Channeling Investments
14.5.1.
By Country
14.5.2.
By Therapy Type
14.5.3.
By Magnetic Stimulation Technique
15. Competitive
Benchmarking
15.1. Market Share
Analysis, 2018
15.2. Global
Presence and Growth Strategies
15.2.1.
Mergers and Acquisitions
15.2.2.
Product Launches
15.2.3.
Investments Trends
15.2.4.
R&D Initiatives
16. Player
Profiles
16.1. Abbott
Laboratories
16.1.1.
Company Details
16.1.2.
Company Overview
16.1.3.
Product Offerings
16.1.4.
Key Developments
16.1.5.
Financial Analysis
16.1.6.
SWOT Analysis
16.1.7.
Business Strategies
16.2. Boston
Scientific Corporation
16.2.1.
Company Details
16.2.2.
Company Overview
16.2.3.
Product Offerings
16.2.4.
Key Developments
16.2.5.
Financial Analysis
16.2.6.
SWOT Analysis
16.2.7.
Business Strategies
16.3. LivaNova PLC
16.3.1.
Company Details
16.3.2.
Company Overview
16.3.3.
Product Offerings
16.3.4.
Key Developments
16.3.5.
Financial Analysis
16.3.6.
SWOT Analysis
16.3.7.
Business Strategies
16.4. Medtronic
16.4.1.
Company Details
16.4.2.
Company Overview
16.4.3.
Product Offerings
16.4.4.
Key Developments
16.4.5.
Financial Analysis
16.4.6.
SWOT Analysis
16.4.7.
Business Strategies
16.5. NeuroPace,
Inc.
16.5.1.
Company Details
16.5.2.
Company Overview
16.5.3.
Product Offerings
16.5.4.
Key Developments
16.5.5.
Financial Analysis
16.5.6.
SWOT Analysis
16.5.7. Business
Strategies
16.6. Other Market
Participants
17. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
